Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
55.75
-0.60 (-1.06%)
At close: Nov 20, 2026, 4:00 PM EST
55.95
+0.20 (0.36%)
After-hours: Nov 20, 2026, 7:43 PM EST
Axogen Market Cap
Axogen has a market cap or net worth of $3.33 billion as of November 20, 2026. It is the 4,553rd most valuable company in the world and the 1,393rd biggest in the United States. Its market cap has increased by 185.84% in one year.
Market Cap
3.33B
Enterprise Value
3.00B
1-Year Change
185.84%
Global Rank
Country Rank
#1,393 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Axogen's market cap has increased from $12.20M to $3.33B, an increase of 27,194.98%. That is a compound annual growth rate of 22.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.33B | 120.59% |
| Dec 31, 2025 | 1.51B | 108.13% |
| Dec 31, 2024 | 725.30M | 146.70% |
| Dec 29, 2023 | 294.00M | -30.33% |
| Dec 30, 2022 | 422.00M | 8.37% |
| Dec 31, 2021 | 389.40M | -45.79% |
| Dec 31, 2020 | 718.30M | 1.73% |
| Dec 31, 2019 | 706.10M | -10.63% |
| Dec 31, 2018 | 790.10M | -16.55% |
| Dec 29, 2017 | 946.80M | 219.76% |
| Dec 30, 2016 | 296.10M | 98.19% |
| Dec 31, 2015 | 149.40M | 113.43% |
| Dec 31, 2014 | 70.00M | -10.14% |
| Dec 31, 2013 | 77.90M | 159.67% |
| Dec 31, 2012 | 30.00M | 1.35% |
| Dec 30, 2011 | 29.60M | 97.33% |
| Dec 31, 2010 | 15.00M | -12.79% |
| Dec 31, 2009 | 17.20M | 45.76% |
| Dec 31, 2008 | 11.80M | 118.52% |
| Dec 31, 2007 | 5.40M | 100.00% |
| Dec 29, 2006 | 2.70M | 28.57% |
| Dec 30, 2005 | 2.10M | -65.00% |
| Dec 31, 2004 | 6.00M | 87.50% |
| Dec 31, 2003 | 3.20M | 60.00% |
| Dec 31, 2002 | 2.00M | -60.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 10x Genomics | 6.81B |
| Haemonetics | 5.47B |
| LivaNova | 5.00B |
| iRhythm Holdings | 3.18B |
| TransMedics Group | 2.96B |
| Neogen | 2.30B |
| UFP Technologies | 2.25B |
| Establishment Labs Holdings | 2.06B |